CliffBio
small molecule

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyMaia →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOTHYROXINE SODIUM
Active ingredientLEVOTHYROXINE SODIUM
Strength500MCG/VIAL
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalDecember 2018
Marketing statusRX

More from Maia

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEVOTHYROXINE SODIUM patent cliff — loss of exclusivity — | CliffBio